World's Best Scientists 2026 revealed!
Jacques Cadranel

Jacques Cadranel

D-Index & Metrics

Medicine

D-Index
93
Citations
33847
World Ranking
10832
National Ranking
335

Jacques Cadranel publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Jacques Cadranel sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 610 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 754 publications — 85th percentile

85% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Jacques Cadranel D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Jacques Cadranel sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 399 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 93 D-Index — 47th percentile

47% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Jacques Cadranel is affiliated with Université Paris Cité in France and has a substantial body of research primarily focused on pulmonary and respiratory medicine. Their work spans several subfields, including pathology and forensic medicine, epidemiology, physiology, and rheumatology. The scientist's research covers a variety of medical topics, with particular emphasis on interstitial lung diseases and idiopathic pulmonary fibrosis, systemic sclerosis and related diseases, inflammatory myopathies and dermatomyositis, eosinophilic disorders and syndromes, sarcoidosis and beryllium toxicity research, medical imaging and pathology studies, and the long-term effects of COVID-19.

Cadranel has contributed to the scientific literature through publications in numerous peer-reviewed journals. Frequent publication venues include:

  • Revue des Maladies Respiratoires Actualités
  • La Revue de Médecine Interne
  • Revue des Maladies Respiratoires
  • European Respiratory Journal
  • Annals of the Rheumatic Diseases

Notable recent papers authored or coauthored by Cadranel include:

  • The identification and management of interstitial lung disease in systemic sclerosis: evidence-based European consensus statements, 2020, The Lancet Rheumatology
  • Different phenotypes in dermatomyositis associated with anti-MDA5 antibody, 2020, Neurology
  • Methotrexate and rheumatoid arthritis associated interstitial lung disease, 2020, European Respiratory Journal
  • Rituximab and mycophenolate mofetil combination in patients with interstitial lung disease (EVER-ILD): a double-blind, randomised, placebo-controlled trial, 2023, European Respiratory Journal
  • Predictors of mortality in fibrosing pulmonary sarcoidosis, 2020, Respiratory Medicine

Frequent collaborators in Cadranel's research efforts include:

  • Hilario Nunès
  • Raphaël Borie
  • Vincent Cottin
  • Pierre-Yves Brillet
  • Bruno Crestani

The volume of publications, especially in pulmonary and respiratory medicine, reflects a focused engagement with diseases affecting the lungs and associated systemic conditions. The topics of interest and coauthorship network suggest multidisciplinary collaboration across related medical fields. Publications span clinical trials, consensus statements, and observational studies, underscoring a blend of evidence-based approaches and clinical research.

Best Publications

  • Diagnosis and management of Aspergillus diseases: executive summary of the 2017 ESCMID-ECMM-ERS guideline

    A. J. Ullmann;J. M. Aguado;S. Arikan-Akdagli;D. W. Denning

  • Afatinib versus placebo for patients with advanced, metastatic non-small-cell lung cancer after failure of erlotinib, gefitinib, or both, and one or two lines of chemotherapy (LUX-Lung 1): a phase 2b/3 randomised trial

    Vincent A. Miller;Vincent A. Miller;Vera Hirsh;Jacques Cadranel;Yuh Min Chen

  • Long-Term Survival for Patients With Non–Small-Cell Lung Cancer With Intratumoral Lymphoid Structures

    Marie-Caroline Dieu-Nosjean;Martine Antoine;Claire Danel;Didier Heudes

  • Chronic pulmonary aspergillosis: rationale and clinical guidelines for diagnosis and management

    David W. Denning;Jacques Cadranel;Catherine Beigelman-Aubry;Florence Ader

  • An official European Respiratory Society/American Thoracic Society research statement: interstitial pneumonia with autoimmune features

    Aryeh Fischer;Katerina M. Antoniou;Kevin K. Brown;Jacques Cadranel

  • Routine molecular profiling of patients with advanced non-small-cell lung cancer: results of a 1-year nationwide programme of the French Cooperative Thoracic Intergroup (IFCT)

    Fabrice Barlesi;Julien Mazieres;Jean-Philippe Merlio;Didier Debieuvre

  • Effect of immunodeficiency, HIV viral load, and antiretroviral therapy on the risk of individual malignancies (FHDH-ANRS CO4): a prospective cohort study

    Marguerite Guiguet;François Boué;Jacques Cadranel;Jean-Marie Lang

  • COVID-19 in patients with thoracic malignancies (TERAVOLT): first results of an international, registry-based, cohort study.

    Marina Chiara Garassino;Jennifer G. Whisenant;Li Ching Huang;Annalisa Trama

  • Primary pulmonary lymphoma

    J Cadranel;M Wislez;M Antoine

  • Multicentric Castleman's disease in HIV infection: a clinical and pathological study of 20 patients.

    Eric Oksenhendler;Monica Duarte;Jean Soulier;Patrice Cacoub

  • Nivolumab or nivolumab plus ipilimumab in patients with relapsed malignant pleural mesothelioma (IFCT-1501 MAPS2): a multicentre, open-label, randomised, non-comparative, phase 2 trial

    Arnaud Scherpereel;Julien Mazieres;Laurent Greillier;Sylvie Lantuejoul

  • Incidence of Non–AIDS-Defining Cancers Before and During the Highly Active Antiretroviral Therapy Era in a Cohort of Human Immunodeficiency Virus–Infected Patients

    Magid Herida;Murielle Mary-Krause;Régis Kaphan;Jacques Cadranel

  • Immune-checkpoint inhibitors associated with interstitial lung disease in cancer patients

    Myriam Delaunay;Jacques Cadranel;Amélie Lusque;Nicolas Meyer

  • Prognostic Factors and Outcome of Human Herpesvirus 8–Associated Primary Effusion Lymphoma in Patients With AIDS

    Emmanuelle Boulanger;Laurence Gérard;Jean Gabarre;Jean-Michel Molina

  • Cisplatin in the modern era: The backbone of first-line chemotherapy for non-small cell lung cancer.

    D Fennell;Yvonne J Summers;J Cadranel;T Benepal

  • A randomized phase II study of the MEK1/MEK2 inhibitor trametinib (GSK1120212) compared with docetaxel in KRAS-mutant advanced non-small-cell lung cancer (NSCLC)

    George R Blumenschein;E. F. Smit;D. Planchard;D. W. Kim

  • Interstitial lung disease in amyopathic dermatomyositis, dermatomyositis and polymyositis

    V. Cottin;F. Thivolet-Bejui;M. Reynaud-Gaubert;J. Cadranel

  • Immune checkpoint inhibitor-related myositis and myocarditis in patients with cancer

    Mehdi Touat;Thierry Maisonobe;Samuel Knauss;Omar Ben Hadj Salem

  • Rare EGFR exon 18 and exon 20 mutations in non-small-cell lung cancer on 10 117 patients: a multicentre observational study by the French ERMETIC-IFCT network

    M. Beau-Faller;N. Prim;A.-M. Ruppert;I. Nanni-Metéllus

  • Microscopic polyangiitis with alveolar hemorrhage. A study of 29 cases and review of the literature. Groupe d'Etudes et de Recherche sur les Maladies "Orphelines" Pulmonaires (GERM"O"P).

    Dominique Lauque;Jacques Cadranel;Romain Lazor;Jacques Pourrat

Frequent Co-Authors

Vincent Cottin
Vincent Cottin Claude Bernard University Lyon 1
Julien Mazieres
Julien Mazieres Paul Sabatier University
Dominique Valeyre
Dominique Valeyre Université Paris Cité
Fabrice Barlesi
Fabrice Barlesi Institut Gustave Roussy
Nicolas Girard
Nicolas Girard Institute Curie
Jean-François Cordier
Jean-François Cordier Claude Bernard University Lyon 1
Benjamin Besse
Benjamin Besse University of Paris-Saclay
Benoit Wallaert
Benoit Wallaert Institut Pasteur
Eric Oksenhendler
Eric Oksenhendler Université Paris Cité

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring the world of medicine in the USA opens up diverse online degree options and career directions beyond the traditional MD. For those interested in mental health, online psych np programs offer a flexible route to advanced practice nursing, enabling graduates to provide specialized psychiatric care.

If patient care isn’t your path, degrees in healthcare management may be appealing. Earning health administration degrees online can prepare you for roles in coordination, strategy, and leadership within healthcare institutions. For those comparing the financial aspects, understanding the cost of mha degree programs can help you choose an option that fits your budget and career goals.

Ambitious nursing professionals may also seek doctoral-level qualifications. The most affordable dnp programs can advance your expertise in clinical practice and leadership. These flexible online pathways allow you to tailor your education and carve out new career opportunities within the healthcare field.

Best Scientists Citing Jacques Cadranel

Trending Scientists

Recently Published Articles